A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo
- Conditions
- Interventions
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 220
- Registration Number
- NCT03333538
- Locations
- 🇷🇺
Research Institute of Influenza, Sankt-Peterburg, Russian Federation
Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis.
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2017-12-27
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 60
- Registration Number
- NCT03255278
- Locations
- 🇷🇺
Sechenov First Moscow State Medical University, Moscow, Russian Federation
An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 25
- Registration Number
- NCT03205462
- Locations
- 🇷🇺
Federal State Budget-Funded Educational Institution for Additional Professional Education "Russian Medical Academy for Postgraduate Education" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 36
- Registration Number
- NCT03137927
- Locations
- 🇷🇺
Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department, Moscow, Russian Federation
International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi
- Conditions
- Interventions
- First Posted Date
- 2017-03-07
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 2000
- Registration Number
- NCT03072030
- Locations
- 🇬🇳
Centre de recherche en épidémiologie, microbiologie et de soins médicaux (CREMS) de Pastoria à Kindia, Kindia, Guinea
🇷🇺Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department, Moscow, Russian Federation
Open Study of the Duration of Immunity After Vaccination With GamEvac
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2017-12-27
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 60
- Registration Number
- NCT02911428
- Locations
- 🇷🇺
Federal state budget military educational institution of higher education "Military medical Academy named after S. M. Kirov" Ministry of defense of the Russian Federation, Saint Petersburg, Russian Federation
Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2017-12-27
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 60
- Registration Number
- NCT02911415
- Locations
- 🇷🇺
Federal state budget military educational institution of higher education "Military medical Academy named after S. M. Kirov" Ministry of defense of the Russian Federation, Saint Petersburg, Russian Federation